Western Kentucky University

TopSCHOLAR®
Masters Theses & Specialist Projects

Graduate School

6-1981

The Biological Effect of Evernimicin B on Bacillus
Subtilis W2 3 and Three Antibiotic-Resistant
Strains of Staphylococcus Aureus
Steven Bogach
Western Kentucky University

Follow this and additional works at: https://digitalcommons.wku.edu/theses
Part of the Biology Commons, and the Immunology of Infectious Disease Commons
Recommended Citation
Bogach, Steven, "The Biological Effect of Evernimicin B on Bacillus Subtilis W2 3 and Three Antibiotic-Resistant Strains of
Staphylococcus Aureus" (1981). Masters Theses & Specialist Projects. Paper 2168.
https://digitalcommons.wku.edu/theses/2168

This Thesis is brought to you for free and open access by TopSCHOLAR®. It has been accepted for inclusion in Masters Theses & Specialist Projects by
an authorized administrator of TopSCHOLAR®. For more information, please contact topscholar@wku.edu.

Bogach,
Steven Joel
1981

THE BIOLOGICAL EFFECT OF EVERNINOMICIN B ON BACILLUS SUBTILIS
h23 AND THREE ANTIBIOTIC-RESISTANT STRAINS OF
STAPHYLOCOCCUS AUREUS

A Thesis
Presented to
the Faculty of the Department of Biology
Western Kentucky University
Bowling Green, Kentucky

In Partial Fulfillment
of the Requirements for the Degree
Master of Science

by
Steven Joel Bogach
June, 1981

AUTHORIZATION FOR. USE OF THESIS

Permission is hereby
granted to the Western Kentucky University Library to
make, or allow to be made photocopies, microfilm or other
copies of this thesis for appropriate research or scholarly
purpo se s.

to the author for the making of any copies of this
J thesis except for brief sectiont. for research or scholarly
purposes.

ri reserved

Signed

Date

frf

Please place an "X" in the appropriate box.
This form will be filed with the original of the thesis and will control
future use of the thesis.

THE BIOLOGICAL EFFECT OF EVERNINOMICIN B ON BACILLUS SUBTILIS
W23 AND THREE ANTIBIOTIC-RESISTANT STRAINS OF
STAPHYLOCOCCUS AUREUS

Recommended

Director of Thesis

r

Approved
Date)

(
\7;•-tean of the Graduate College

ACKNOWLEDGMENTS

I would like to express my appreciation to Dr. R. A.
Brown for her guidance throughout the course of this study.
I would also like to express my appreciation to Drs.
Martin Houston and Eugene Hoffman for their heir: and
technical assistance.

Sincere appreciation is also extended

to Mr. Rodney McCurry for his assistance in electron
microscopy and Ms. Yvonne Stifel for her friendship and
assistance with media and graphics used in this study.
This thesis is dedicated to my wife, Margaret Jane Bogach,
whose love and unerring faith in my abilities made this
accomplishment possible.

We did it, Sweetheart.

iii

TABLE OF CONTENTS

page

ACKNOWLEDGMENTS

111

LIST OF FIGURES
LIST OF TABLES

vi

ABSTRACT

vii

INTRODUCTION

1

MATERIALS AND METHODS
Compound Preparation for Bacterial Testing
Microorganisms
Bacterial Culture Media
Tube Dilution Protocol
Growth Experiments
Viability Determinations
Electron Microscopy

8
8
8
9
9
11
11
12

RESULTS
Minimum Inhibitory Concentrations
Reversibilities
Growth Studies
Viability Determinations
Electron Microscopy

14
14
14
17
26
30

DISCUSSION AND CONCLUSIONS

33

LITERATURE CITED

37

iv

LIST OF FIGURES
page
Figure

Figure

Figure

Figure

Figure

Figure

Figure

Figure

Figure

1.

2.

3.

4.

5.

6.

7.

8.

9.

Figure 10.

Figure 11.

Figure 12.

Structure of Everninomicin B and
Everninomicin D

6

Effect of Everninomicin B on the
growth of Bacillus subtilis W23

18

Effect of Everninomicin B on the
growth of penicillin-resistant
Staphylococcus aureus

19

Effect of growth conditions on the
stability of Everninomicin B after
72 hours of cell-free incubation

21

Effect of initial inoculum size on
Everninomicin B-induced growth
inhibition of Bacillus subtilis W23

22

Effect of initial inoculum size on
Everninomicin B-induced growth
inhibition of penicillin-resistant
Staphylococcus aureus

24

Effect of time of addition on
Everninomicin B-induced growth
inhibition of Bacillus subtilis W23

.

25

Effect of time of addition on
Everninomicin B-induced growth
inhibition of penicillin-resistant
Staphylococcus aureus

27

Effect of Everninomicin B on the
viability of Bacillus subtilis W23

28

Effect of Everninomicin B on the
viability of penicillin-resistant
Staphylococcus aureus

29

Electron micrographs of untreated
penicillin-resistant Staphylococcus
aureus

31

Electron micrographs of Everninomicin Btreated penicillin-resistant
Staphylococcus aureus

32

MI6

LIST OF TABLES
page

Table 1.

Table 2.

Table 3.

Antibiotics produced by
Micromonospora

3

Minimum inhibitory concentration
determinations for Bacillus subtilis
W23 and three antibiotic-resistant
strains of Staphylococcus aureus

15

Reversibility of Everninomicin Binduced inhibition for Bacillus
subtilis W23 and three antibioticresistant strains of Staphylococcus
aureus

16

THE BIOLOGICAL EFFECT OF EVERNINOMICIN B ON BACILLUS SUBTILIS
W23 AND THREE ANTIBIOTIC-RESISTANT STRAINS OF
STAPHYLOCOCCUS AUREUS
Steven J. Bogach
Directed by:

38 pages

June, 1981

Rebecca A. Brown, M. R. Houston, F. J. Hoffman,
and J. R. McCurry
Western Kentucky University

Department of Biology

One strain of Bacillus subtilis and three antibioticresistant strains of Staphylococcus aureus were employed to
determine the biological effects of everninomicin B (EvB), a
naturally occurring antibiotic produced by Micromonospora
carbonacea (NRRL 2972) and M. carbonacea var. aurantiaca.
Minimum inhibitory concentration (MIC) of EvB for B. subtilis
was

-3
pmole/m1 of EvB in glucose minimal broth and 2.6
1.2 x 10

-3
wmole/m1 of EvB in nutrient broth.
x 10

MIL values of EvB

-4
,.,mole/m1 of EvB rol strains
for S. aureus were 3.25 x 10
-4
umole/ml
resistant to penicillin or tetracycline and 6.5 x 10
of EvB for the aminoglycoside-resistant strain.

The inhibitory

effect of EvB was found to be reversible for all concentrations
of EvB and all bacterial strains tested.

The inhibitory effect

of EvB for B. subtilis was not dependent upon the initial concentration of cells nor the stage in the growth cycle at the
time the compound was introduced.

The inhibitory effect was

dependent upon the initial concentration of cells for S. aureus.
Electron microscopy studies showed distinct morphological changes
in treated cells of S. aureus.

Cellular lysis in these cells

was also detected.
vii

INTRODUCTION

In 1904 Ehrlich first described the feasibility of
using detoxified poisons (such as arsenic) to treat infections.
Since then researchers have been isolating and chemically
synthesizing many types of antimicrobial agents.

In 1929

Fleming noticed that certain fungal metabolites would inhibit
bacterial growth.

These fungal metabolites were termed

antibiotics (Rogers, 1969).
There are at least five modes of action by which antibiotics inhibit bacterial growth:

(1) interruption of

necessary biochemical pathways, (2) inhibition of cell wall
synthesis, (3) inhibition of DNA or RNA synthesis, (4) inhibition of protein synthesis, and (5) physical damage to
the cell membrane (Richmond, 1966).
The first and most important antibiotic to be used was
penicillin.

Penicillin is a naturally occurring antibiotic

produced by the fungus Penicillinm notatum and is one of many
antibiotics which inhibit peptidoglycan (cell wall) synthesis
(Park and Strominger, 1957).

When the cell wall cannot be

synthesized the osmotically fragile protoplast will lyse
(Hancock and Fitz-James, 1964).
When antibiotics became commonly used, antibioticresistant bacteria were selected for and became a major
medical problem.

Antibiotic-resistant bacteria are those

bacteria with the genetic ability to resist the
1
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effects of an antibiotic (Kazuo et al., 1966).

As the types

and strains of antibiotic-resistant bacteria increased, the
need for new and effective antibiotics became evident.
The genus Micromonospora produces five families of clinically beneficial antibiotics (Table 1) and several antibiotics which have been isolated but not fully described
(Wagman and Weinstein, 1980).

The aminoglycosides are the

most prominent of the antibiotics produced by Micromonospora.
The most clinically utilized aminoglycoside is gentamicin
which is a water-soluble antibiotic synthesized by M. purpurea
that has an unusually broad spectrum and can inhibit the
growth of antibiotic-resistant bacteria such as Proteus and
Pseudomonas (Wagman and Weinstein, 1980; Rosselet et al.,
1964; Oden et al., 1964).

Its broad spectrum and low toxicity

for the host organism makes it an excellent antibiotic of
choice against gram-negative bacteria (Wagman and Weinstein,
1980).

Gentamicin is known to bind irreversibly to the

305 ribosomal subunit which prevents translation during
protein synthesis (Petska, 1971).
The macrolides produced by Micromonspora can inhibit
bacterial growth only at an alkalinr pH and have mainly
a gram-positive spectrum (Wagman and Weinstein, 1980).

The

macrolides inhibit bacterial growth by binding to the 50S
ribosomal subunit which prevents protein synthesis (Petska,
1971.
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The ansamysins have been isolated from many species
of Micromonspora.

Included in this family are the halo-

mycins and rifamicins (Weinstein et al., 1968).

The ansa-

mycins prevent bacterial growth by inhibiting DNA-dependent
Rna polymerase thus preventing RNA synthesis. Mammalian
cells have been found to contain a RNA polymerase insensitive to rifamicins , and the cells are not known to be
affected (Wehrli and Staehelin, 1971).
Actinomysins are peptide containing antibiotics with a
broad spectrum and a high degree of host toxicity (Reich,
1964).

These antibiotics are the most potent and specific

inhibitiors of DNA-dependent RNA synthesis (Gellert et al.,
1965).

The actinomycins have been used to study viral

replication and RNA function in prolaryotic and eukaryotic
systems (Reich et al., 1962).

Kirk (1962) showed that in

mammalian systems, the actinomycins form reversible complexes
with DNA.

The modes of action of the actinomycins are:

(1) prevention of DNA polymerization, (2) condensation of
chromatin, and (3) the loss of nuclear functions which
require the physical involvement of DNA (Reich et al.,
1962).
The everninomicins are a family of five related antibiotics designated A, B, C, D, and E.

The are naturally

synthesized by M. carbonacea (NRRL 2972) and M. carbonacea var. aurantiaca (Wagman et al., 1965).

The everninomicins

are composed of a dichloroseverinic acid complexed with a polysacharide moeity (Herzog et al., 1965).

Pharmacological

4

Table 1.

Antibiotics Produced by Micromonospora

Family

Generic Name of Antibiotic

AMINOGLYCOSIDES
Gentamic ins
Sisomycin
Verdamicin
Antibiotic G-52
Fortimicins
Neomycins
Antibiotic 460
Sagamicin
MACROLIDES
Megalomicins
Rosaramicin
Juvenimicins
M-4365 Complex
Erythromycin B
ANSAMYSINS
Halomycins
Rifamicins
EVERNINOMICINS
Everninomicin
Everninomicin
Everninomicin
Everninomicin
Everninomicin
ACTINOMYCINS
Actinomycin C
Actinomycin D
MISCELLANEOUS ANTIBIOTICS*

*Isolated but not yet- fully described.

A
B
C
D
E
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research with everninomicin D (EvD) showed that EvD had
In mice, EvD was shown to have

extremely low host toxicity.

a 1,D50 of 3700 wg/kg when injected subcutaneously and 125 pg
when injected intravenously (Weinstein, et al., 1965).

Their

study showed that when EvD was administered subcutaneously
t would provide in vivo protection for mice against lethal
strains of Staphylococcus aureus, Steptococcus pyogenes,
and Diplococcus pneumoniae.

The amount needed for complete

protection against these bacterial infections was comparable
to penicillin G, methicillin, or oxacillin (Weinstein, et al.,
1965).
Black, et al., (1965) also researched the pharmacological
effect of EvD.

In their study they utilized mice, dogs (beagle

hounds), and human beings.

Their results showed that EvD

readily binds to human serum (94%).

The rapidity of serum

binding by the antibiotic greatly diminished the antimicrobial
effect.

In addition, subcutaneous administration resulted in

poor adsorption in muscle and the compound was excreted via
urinary and biliary routes.

Other problems included finding

a suitable vehicle for injection, eliminating soreness at the
site of injection, and overcoming a distinct organic solvent
taste when administered orally.
Sanders and Sanders (1978) showed that EvB (which is
structurally similar to EvD) (Figure 1) had primarily a grampositive spectrum.

Sensitive gram-negative bacteria are in the

genera Bacterioides, Hemophilus, and Neisseria.

They also

Fiuro 1.

Structure of Everninomicin B and Everninomicin D.
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showed that 73 strains of antibiotic-resistant gram-positive
bacteria were sensitive to EvB.

Their results indicated

that there was no de novo resistance in any of the bacteria
tested.

Because antibiotic-resistant bacteria are sensitive

to EvB and no resistance to the compound has been demonstrated,
it was suggested that EvB may have a novel mode of action
not previously described (Sanders and Sanders, 1978).
The objectives of this project were to (1) find the
minimum inhibitory concentration of EvB needed to inhibit
the growth of Bacillus subtilis W23 and three antibioticresistant strains of Staphylococcus aureus, (2) determine
the reversibility of EvB-induced inhibition for Bacillus
subtilis W23 and three antibiotic-resistant strains of
Staphylococcus aureus, (3) determine if the effect of EvB
is dependent upon the initial concentration of cells of
actively growing cultures of Bacillus subtilis W23 and
penicillin-resistant Staphylococcus aureus, (4) determine
the effect of EvB on the viability of Bacillus subtilis W23
and penicillin-resistant Staphylococcus aureus and (5)
visualize any physical effects that EvB might have upon
the penicillin-resistant Staphylococcus aureus using
electron microscopy.

MATERIALS AND METHODS

Preparation of Everninomicin B for Bacterial Testing
The compound used in this study was everninomicin B
(EvB) originally obtained from the Schering Corporation,
Bloomfield, New Jersey.

EvB, a white amorphous powder, was

kept in a screw-top vial and stored at 5°C.

A stock solution

was prepared by placing 0.005 g of EvB and 0.5 ml of dimethylsulfoxide (DMSO) into a sterile cap-all test tube.

Sterile

distilled water (4.5 ml) was then added bringing the final
concentration of the solution to 0.63 wmole of EvB/ml.

Stock

solutions of EvB were stored in cap-all test tubes at 5°C.
For experimentation appropriate dilutions were made of the
stock solutions.

Microorganisms
Bacillus subtilis W23 was obtained from the collection
of Dr. R. A. Brown, Western Kentucky University, Bowling
Green, Kentucky.

Stock cultures of B. subtilis W23 were

maintained on glucose minimal agar slants at 50C.
Three strains of antibiotic-resistant Staphylococcus
aureus (wild strains) were clinically isolated at Greenview
Hospital, Bowling Green, Kentucky.

The three antibiotic-

resistant strains employed were resistant to either penicillin,
tetracycline, or aminoglycosides.

All three strains were found

to be gram-positive cocci in clusters, catalase positive,
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coagulase positive, and positive for mannitol fermentation.
The S. aureus strains were maintained on slants of brain
heart infusion agar at 5°C.

Bacterial Culture Media
Glucose minimal medium used in this study was composed
of 0.2% (w/v) NaC1, 0.2% (w/v) (NH4)2SO4, 0.32% (w/v) KH2PO4,
and 5% (w/v) glucose.

The basal medium was prepared by

dissolving the NaC1, (NH4)2SO4, and KH2PO4 in deionized
distilled water and adjusting the pH to 7 with 1M KOH.

The

basal medium was autoclaved at 121°C for 15 minutes.
Prior to use the basal medium was cooled to 25oC.

A stock

solution of 10% (w/v) glucose and a mineral salts solution
were prepared and autoclaved separately.

The mineral salts

solution was composed of 5% (w/v) MgSO4 -7H20, 1% (w/v) MnSO4,
and 0.5% (w/v) CaC1

3

in deionized distilled water.

The basal

medium was supplemented with 0.1 ml mineral salts solution for
each 100 ml basal medium, and glucose added to a final concentration of 5% (v/v).

Agar (DIFCO) was added to a final

concentration of 1.5% (w/v) for solid medium.
Brain heart infusion broth and brain heart infusion
agar (DIFCO) were used in the cultivation of S. aureus.
These media were made and sterilized in accordance with
label instructions.

Tube Dilution
The tube-dilution protocol was used to determine the
minimum inhibitory concentration (MIC) of EvB for the
bacteria tested.

Twelve test tubes were used for each

10

bacterium tested.

One ml of the appropriate breth

Was

dispensed into each test tube except for the first test
Two ml of appropriate broth containing 2.1 x 10-2

tube.

umo1e/m1 of EvB were added to the first test tube.

Serial

two-fold dilutions were made starting from 2.1 x 10-2 pmole
-5
of EvB/m1 and ending with 1.05 x 10
umole of EvB/ml.
Bacteria from the stock cultures were inoculated into
9 ml of sterile broth and incubated for 18 hours at 36°C
on a rotary shaker.

The broth culture was diluted 1:100 and

one ml was dispensed into each of the 12 test tubes.

The

final concentrations of EvB after the addition of inoculum
-2
-3
-3
were 1.05 x 10 , 5.2 x 10 , 2.6 x 10 , 1.3 x 10-3, 6.5 x
-4
-4
-4
-5
10 , 3.25 x 10 , 1.63 x 10 , 8.13 x 10 , 4.10 x 10-5,
-5
-5
-6
2.03 x 10 , 1.02 x 10 , and 5.08 x 10
umole/ml, respectively.
The twelve test tubes were incubated for 13 hours at 36oC
on a rotary shaker and checked for visible growth.

The

highest dilution without visible growth was the MIC.
Reversibility was determined by removing 0.1-ml aliquots
from all cultures showing no growth in each series and
inoculating them into 5 ml of sterile broth.

These subcultures

were then incubated for 18 hours at 36°C on a rotary shaker.
After incubation the culture test tubes were checked for
visible growth.

The highest dilution without visible growth

was considered to he the minimum bacteriocidal concentration
(MBC).

If all the tubes showed visible growth, the effect of

the compound was considered to be reversible.
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Growth Experiments
Stock culture from an agar slant was loop inoculated into
o
9 ml of sterile broth and then incubated for 18 hours at 36 C
on a rotary shaker.

These 18-hour cultures were then used

as inocula for further experimentation.

For growth studies,

cells were inoculated into sterile test tubes (150 x 15 mm)
containing 5.0 ml sterile broth.
in all growth studies.

Two growth controls were used

Control A was made by adding only

sterile distilled water and control B by adding only DMSO
stock solution to the test tube.

Added to the experimental

test tubes were appropriate concentrations of EvB.

All test

tubes were inoculated to the desired optical density (between
Cell growth was monitored spectrophoto-

0.06 and 0.08 units).

metrically at 540 nm using a Bausch and Lomb Spectronic 20 with
an 18-mm light path.

Growth was monitored at hourly intervals

for 8 hours with a final reading at 24 hours.

Viability Determinations
Two side-arm flasks containing 25 ml of culture broth
were inoculated to an optical density of 0.10 units.
control flask, only sterile distilled water was added.

To the
EvB

was placed into the second side-arm flask at a concentration
-2
of 1.3 x 10
'omole/ml.

Both flasks were incubated at 16°C

until the optical density in the control flask reached 0.13
units.

At designated times, one-ml aliquots from each side-

arm flask were placed into separate 99-ml dilution blanks
containing potassium phosphate buffer (pH 7.2).

These dilution

blanks were then shaken (25 one-foot strokes in 7 seconds) and
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serial ten-fold dilutions were made starting from 10-2 and
ending with 10-9.

Each dilution was plated in duplicate using

the appropriate agar and incubated for 24 hours at 36°C.
Those plates showing between 30 and 300 colonies were counted
using a Quebec Colony Counter.

Electron Microscopy
A 0.5% (w/v) solution of formvar in chloroform was
prepared and allowed to stand at 25oC for 24 hours.

A

microscope slide was immersed in the formvar solution, and
the chloroform was allowed to evaporate.

Using a new razor

blade, a series of slices were made on the periphery of the
slide to initially release the formvar which was then loosened
by gently blowing on the slide.

The loosened formvar was

then floated onto the surface of clean distilled water in a
500-ml culture dish.

Copper grids were placed onto the floating

formvar sheet, and a pre-cleaned glass slide was placed over
the formvar sheet and grids.
and allowed

This slide was removed, inverted

to dry overnight at 25°C in a dust-free environment

Cells of S. aureus were treated with 1.3 x 10-3 .,Imole of
EVE per ml and allowed to incubate for 18 hours at 36oC on a
rotary shaker.

Controls were grown in brain heart infusion

broth in which sterile distilled water was substituted for EvB
and incubated for 18 hours at 36oC on a rotary shaker.

All

cells were centrifuged at 10,000 x g for 15 minutes in a
Sorval 55-1 centrifuge.

The supernatant was discarded and

the cells washed three times in potassium phosphate buffer

13

(pH 7.2).

After washing the cells were dropped onto formvar

grids with a pasteur pipet.

A drop of 7% uranyl acetate was

placed onto the grids with the cells for negative staining.
The formvar grids were then blotted to dryness on cellulose
filter-paper disks, and the grids were observed with a Zeiss
EM 9S-2 electron microscope.

RESULTS

Minimum Inhibitory Concentrations
The MIC of EvB when using Bacillus subtilis W23 grown
-3
omole of EvB per ml.
in glucose minimal broth was 1.3 x 10
The MIC of EvB when B. subtilis W23 was grown in nutrient
-3
,:mole of EvB per ml.
broth was 2.6 x 10

This represented

a two-fold increase in MIC (Table 2) when the media were
changed.
The MIC of EvB for the three antibiotic-resistant strains
of S. aureus

was

-4
. mole of EvB per ml for the
3.25 x 10

penicillin-resistant strain and the tetracycline-resistant
strain

-4
and 6.5 x 10

mole of EvB per ml for the strain

of S. aureus resistant to aminoglycosides (Table 2).

Reversibilities
The reversibility of EvB-induced inhibition was determined
for all bacterial strains used in this study.

B.

subtilis

was subcultured into fresh medium from all negative tubes.

W23
For

cells grown in glucose minimal broth this represented con-3
-2
centrations of EvB starting from 1.3 x 10
to 1.05 x 10
omole/ml.

When grown in nutrient broth, the concentrations

-3
of EvB from the negative growth cultures ranged from 2.6 x 10
-2
to 1.05 x 10
omole/ml.

The results indicated that the

effect of the compound was reversible for B. subtilis W23 for
all concentrations of EvB tested (Table 3).
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TABLE 2

MINIMUM INHIBITORY CONCENTRATION DETERMINATIONS FOR
BACILLUS SUBTILIS W23 AND THREE ANTIBIOTICRESISTANT STRAINS OF STAPHYLOCOCCUS AUREUS

pmole of EvB/m1

a
S. aureus
P-R
T-R
A-R

B. subtilisb
RS
GMMB

-2
1.05 x 10

_c

_

_

_

_

-3
5.20 x 10

_

_

_

_

_

-3
2.60 x 10

_

_

_

_

_

-3
1.30 x 10

-

-

-

d
+

-

-4
6.50 x 10

-

-

-

+

+

-4
3.25 x 10

_

_

+

+

+

-4
1.63 x 10

+

+

+

+

+

-5
8.13 x 10

+

+

+

+

+

-5
4.10 x 10

+

+

+

+

+

-5
2.03 x 10

+

+

+

+

+

-5
1.02 x 10

+

+

+

+

+

-6
5.08 x 10

+

+

+

+

+

a
P-R:
T-R:
A-R:

penicillin-resistant strain
tetracycline-resistant strain
aminoglycoside-resistant strain

b
NB: B. subtilis grown in nutrient broth
GMMB: B. subtilis grown in glucose minimal broth
c
negative growth
d

positive growth
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TABLE 3

REVERSIBILITY OF EVERNINOMICIN-B-INDUCED INHIBITION
FOR BACILLUS SUBTILIS W23 AND THREE ANTIBIOTICRESISTANT STRAINS OF STAPHYLOCOCCUS AUREUS

a
S. aureus
oriole of EvB/m1

P-R

T-R

A-R

B. subtilis
NB

GMMB

-2
1.05 x 10

c
+

+

+

+

+

-3
5.20 x 10

+

+

+

+

+

-3
2.60 x 10

+

+

+

+

+

-3
1.30 x 10

+

+

+

+

+

-3
6.50 x 10

+

+

+

+

+

a
P-R:
T-R:
A-R:

penicillin-resistant strain
tetracycline-resistant strain
aminoglycoside-resistant strain

b

NB: B. subtilis grown in nutrient broth
GMMB: B. subtilis grown in glucose minimal broth

c
positive growth
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All negative cultures from antibiotic-resistant
S. aureus were subcultured into fresh brain heart infusion
broth.

The concentrations of EvB of the negative growth

-4
-2
cultures ranged from 3.25 x 10
to 1.05 x 10
illio1e/m1
for the penicillin- and tetracycline-resistant strains and
-4
-2
6.5 x 10
to 1.05 x 10
to aminoglycosides.

fllole/m1 for the strain resistant

The results indicate that the effect

of the compound was reversible for all concentrations
of EvB tested for the three antibiotic-resistant strains
(Table 3).

Growth Studies
B. subtilis W23 was inoculated into glucose minimal
-3
broth with EvB at a concentration of 6.5 x 10
,mole/m1
which represented a five-fold increase of the MIC value.

There

was 100% growth inhibition after 24 hours (Figure 2).
Penicillin-resistant S. aureus was grown in brain heart
infusion broth with EvB added at concentrations of 1.3 x 10-3
-3
and 6.5 x 10
umole/m1.

Both concentrations of EvB had the

same effect, 66% growth inhibition when compared to the
controls (Figure 3).
After the initial growth studies were performed, the
stability of compound was investigated to determine if the
effects of incubation (i.e. shaking, temperature, degradation
of compound due to media, or incubation time) could result
in the loss of biological activity of EvB.

Three series of

test tubes containing glucose minimal broth plus 1.3 x 10-2

18

Figure 2.

Effect of Everninomicin B on growth of Bacillus
subtilis W23 (e), glucose minimal broth controls
x 10-3 timo1e/m1 of EvB in glucose minimal
broth.
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Figure 3.

Effect of Everninomicin B on the growth of penicillinresistant Staphylococcus aureus (10), brain hear
infusion controls (i), 6.5 -:i-10-J and 1.3 x 10
umo1e/m1 of EvB in brain heart infusion broth.

4.0
---*---4 I.

2.0

0.2

4

6

8

Tine (Hours)

24

4TT8
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umole/ml of EvB and three control series were incubated cellfree on a rotary shaker at 36°C for 24, 48, and 72 hours.
After each 24-hour cell-free incubation period, B. subtilis
W23 was inoculated into the EvB and control series which were
then incubated for an additional 24 hours at 36°C on a rotary
shaker.

The results showed that after 72 hours of standard

cell-free incubation, EvB did not lose its ability to inhibit
the growth of B. subtilis W23 (Figure 4).
Studies of the effect of initial inoculum size were
used to determine if the inhibitory effect of EvB was
dependent upon the initial concentration of cells in the
culture medium.

B. subtilis W23 was inoculated into four

series of test tubes containing glucose minimal broth and
-3
umole/ml.
EvB at a concentration of 6.5 x 10

The initial

optical densities in the four series were 0.2, 0.2, 0.3, and
0.4 units.

Control test tubes were run for each series and

adjusted to comparable optical densities.

B. subtilis W23

showed 100% inhibition after 24 hours at all optical densities
employed (Figure 5).
The effect of initial inocula size was determined using
penicillin-resistant S. aureus.
kept similar to

All growth conditions were

the previous experiment except that brain

heart infusion medium was used.

At an initial optical

density of 0.1 units S. aureus treated with EvB showed 50%
growth inhibition after 24 hours.

When S. aureus was inoculated

to an initial optical density of 0.2 units the treated cells
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Figure 4.

Effect of growth conditions on the stability of
Everninomicin B after 72 hours cell-free incubation
(40)•, glucose minimal broth controls; (II), 1.3 x
10-z umole/ml of EvB in glucose minimal broth.

Figure 5.

Effect of initial inoculum size on Everninomicin B
induced growth inhibition of Bacillus subtilis W23.
A: initial optical density 0.1 OD units, B: initial
optical density 0.2 OD units, C: initial optical
density 0.3 units, D: initial optical density 0.4 OD
units. (0), glucose minimal broth controls; (II),
6.5 x 10-3 umole/ml of EvB in glucose minimal
broth.
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showed approximately 15% growth inhibition after 24 hours.
At initial optical densities of 0.3 and 0.4 units there was
no EvB-induced inhibition after 24 hours for treated cells
of S. aureus.

These results indicated that the effect of

EvB was dependent upon initial concentration of cells for
S. aureus (Figure 6).
Time-of-addition studies were performed to determine if
EvB had more or less of an inhibitory effect when added at
different times during the incubation period.

B. subtilis

W23 was inoculated into glucose minimal broth at an optical
density of 0.08 units and incubated on a rotary shaker at 36°C
until a change in optical density was detected.

EvB was added

at a concentration of 6.5 x 10-3 .,:mole/ml to the actively
growing cultures at 2-hour intervals.

As the compound was

added, sterile distilled water and DMSO were added to the
controls.

The results showed that when EvB was added at any

time during the incubation period there was 100% inhibition
of growth (Figure 7).
Time-of-addition studies were performed using penicillinresistant S. aureus.

The growth conditions were similar to

the previous experiment except that shorter addition times
were used, and brain heart infusion broth was the medium of
choice.

These studies showed that when EvB was added initially

there was 50t growth inhibition after 24 hours and no inhibition
after 48 hours.

When the compound was added after one hour

to actively growing cultures, there was also 50% growth

Figure 6.

Effect of initial inoculum size on Everninomicin B
induced growth inhibition of penicillin-resistant
Staphylococcus aureus. A: initial optical density
0.1 OD units, B: initial optical density 0.2 OD
units, C: initial optical density 0.3 OD units,
D:
initial optical density 0.4 OD units.._ 3 (0),
:Imole/m1
glucose minimal broth controls; 6.5 x 10
of EvB in brain heart infusion brothll.
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Figure 7.

Effect of time of addition of Everninomicin B induced
inhibition of Bacillus subtilis W23. A: compound
added at time 0, B: compound added after 2 hours
incubation, C: compound added after 4 hours incubation, D: compound added after 6 hours incubation._ 3
(40) glucose minimal broth controls; (IV 6.5 x 10
'mole/m1 of EvB in glucose minimal broth.
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inhibition and no inhibition after 48 hours.

When EvB was

added to approximately two-hour actively growing cultures
there was 33% inhibition of growth and no inhibition after
48 hours.

When the compound was added to S. aureus which had

/
2 hours there was 20% growth
been actively growing for 21
inhibition after 24 hours and no inhibition after 48 hours.
These results indicated that for S. aureus the effect of EvBinduced growth inhibition was dependent upon the time of
addition (Figure 8).

Viability Determinations
Viability determinations were used to determine if EvBinduced inhibition was bacteriostatic or bacteriocidal.

B.

subtilis W23 was grown in glucose minimal broth and plated
on glucose minimal agar.

The results showed that after a

90-minute incubation period there was no increase in colony
forming units/ml (CFU/ml), which indicated that EvB was
bacteriostatic for B. subtilis W23 (Figure 9).
Similar viability determinations as described previously
were performed on the penicillin-resistant S. aureus except
that this strain was grown in brain heart infusion broth and
plated on brain heart infusion agar.

After a 90-minute

incubation period there was no increase in CFU/ml which
indicated that for S. aureus the effect of EvB was bacteriostatic (Figure 10).

Figure 8.

Effect of time of addition on Everninomicin B
induced growth inhibition of penicillin-resistant
Staphylococcus aureus. A: compound added at time
0, B: compound added after 1.0 hours, C: compound
added after 2.25 hours, D: compound added after
2.5 hours. (II), brain hart infusion broth
omole/m1 of EvB in brain
'
controls: (II) 6.5 x 10heart infusion broth.

Figure 9.

Effect of Fverninomicin B on the viability of
Bacillus subtilis W23. (0), glusose minimal
omo1e/m1 of
medium controls; (l). 1.3 x 10
EvB in glucose minimal broth.
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Figure 10.

Effect of Everninomicin B on the viability of
penicillin-resistant Staphylococcus aureus.
(410), brain heart infusion medium controls; (I),
1.3 x 10-2 umole/m1 of EvB in brain heart
infusion broth.
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Electron Microscopy
When control cells of penicillin-resistant S. aureus
were examined with an electron microscope, the cells had
shown typical cluster formation and uniform morphology
(Figure 11).

When the penicillin-resistant S. aureus was

treated with 1.3 x 10-3 Llmole of FvB per ml and incubated
for 18 hours on a rotary shaker at 36°C it was noted that the
treated cells showed marked pleomorphism, and lysis of some
of the treated cells occurred (Figure 12).

31

Figure 11.

Electron micrograph of untreated penicillinresistant Staphylococcus aureus. Note regular
shape of cells within the cluster.
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Figure 12.

Electron micrograph of Everninomicin B treated
penicillin-resistant Staphylococcus aureus. S.
aureus was treated with 1.3 x 10-3 umole/ml of
EvB for 18 hours at 36°C. Note pleomorphic cells
within the cluster and apparent lysis of some of
these cells.

DISCUSSION AND CONCLUSIONS

Micromonospora carbonacea (NRRL 2972) and M. carbonacea
var. aurantiaca have been demonstrated to produce a complex
of antibiotics known as the everninomicins (Wagman, et al.,
1965).

Of the five everninomicins complexes, EvD is produced

in the greatest amount (Herzog, et al., 1965);

because

of this most of the pharmacological research has been done
with EvD (Weinstein, et al., 1964; Black, et al., 1965).
Herzog, et al. (1965) showed that EvD and EvB are structurally
related.

Although EvB has primarily a gram-1-„ositive spectrum

(Black, et al., 1965), Sanders and Sanders (1978) showed that
antibiotic-resistant bacteria are sensitive to EvB.

They

also demonstrated that there was no de novo resistance which
suggested that EvB may have a novel mode of action.

More

research is needed to elucidate possible modes of action of
EvB.
In this study the tube-dilution protocol showed that
the bacterial strains tested were sensitive to the inhibitory
effects of EvB.

This was reflected by the fact that EvB

had low MIC values for all bacterial strains tested.
When B. subtilis was grown in nutrient broth there was
a two-fold increase in the MIC value.

It was possible that

the biological effects of EvB in nutrient broth were decreased
as the natural complex of nutrients in the media increased
33
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(Foster and Pittillo, 1952).

The MIC values for the three

antibiotic-resistant strains of S. aureus agree with the
results of Sanders and Sanders (1978).
Tube-dilution reversibilities showed that the inhibitory
effect was reversible for B. subtilis W23 with concentrations
-3
-2
of EvB ranging from 1.3 x 10
omole/ml when
to 1.05 x 10
B. subtilis was grown in glucose minimal broth and 2.6 x
-3
-2
10
to 1.05 x 10
1„mole/ml when B. subtilis was grown in
nutrient broth.

Tube-dilution reversiblities for three

antibiotic-resistant strains of S. aureus showed that the
inhibitory effect of EvB was reversible with concentrations
-4
-2
to 1.05 x 10
ranging from 3.25 x 10

mole/m1 for the

strains resistant to penicillin or tetracycline and 6.5 x
-4
-2
to 1.05 x 10
umole/ml for S. aureus resistant to
10
aminoglycosides.
In growth studies using B. subtilis W23 and S.
_ aureus
-3
the concentration of EvB used was 6.5 x 10
pmole/ml which
represented a five-fold increase in the MIC value for B. subtilis
and a twenty-fold increase over the MIC value for S. aureus.
At this

concentration the inhibitory effect of EvB against

B. subtilis W23 was not dependent upon the initial concentration of cells nor was it dependent upon when the compound was
added to the actively growing cultures.

The effect of EvB

on penicillin-resistant S. aureus was dependent upon the initial
concentration of cells as well as upon the time of addition
of EvB.

These results indicate that for S. aureus the higher
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the concentration of cells (either actively growing or nongrowing cells) the less inhibition of growth was detected.
Viability determinations for B. subtilis and S. aureus
showed that after a 90-minute incubation period there was
no increase in CFU/ml in the treated cultures.

The results

of the viability determinations and reversibility studies
indicated that EvB was bacteriostatic.
A probable explanation for the differences between
the results of B. subtilis and S. aureus was the difference
in the media.

B. subtilis, often used in antibiotic research,

can be grown in minimal media.

S. aureus can only be grown

in complex media which could reduce the inhibitory effect of
the compound on bacterial growth (Foster and Pittillo, 1952).
Electron microscopy showed that when cells of S. aureus
were exposed to EvB and compared to untreated cells there
were distinct morphological changes in the untreated cells.
These changes included marked pleomorphism and lysis.

It

could not be determined from this study if the lysis of the
treated cells was due to the actual effect of the compound
or if cellular lysis was due to the physical effects of the
vacuum when the cells were placed into the electron microscope.
In evaluating EvB for possible use as a clinically
significant antibiotic, more research is needed to elucidate
its exact mode of action, a suitable vehicle for injection
must be found, and an analogue which will not bind readily to
human serum should be synthesized.

Further alternative
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research should include the possible use of EvB in selective
media, or as a preservative of foodstuffs because of its
low host toxicity.
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